Everything We Know About the Highly Mutated New COVID Variant ‘Cicada’

by Chief Editor

The “Cicada” Variant: A Sign of Things to Come for COVID-19?

It feels almost cyclical at this point – the emergence of a new COVID-19 variant. The latest, nicknamed “Cicada” (BA.3.2), is currently under scrutiny by health officials worldwide. Even as not yet dominant, its ability to potentially evade existing immunity is raising concerns and prompting a closer look at the future of the virus.

A History of Evasion: Why “Cicada”?

The moniker “Cicada” is fitting. Like the insect that spends years underground before resurfacing, BA.3.2 remained largely undetected for a significant period. First detected in the U.S. In 2025 through airport screening, it has since spread, appearing in wastewater samples across at least half the country and in clinical samples from patients. The variant’s slow simmer until recently mirrors the insect’s life cycle and highlights the challenges of continuous surveillance.

What Makes BA.3.2 Different?

BA.3.2 isn’t just another variant; it’s a significantly mutated one. It carries approximately 70 to 75 changes in its spike protein, the part of the virus that allows it to enter human cells. These mutations are distinct from those seen in the JN.1 lineage that previously dominated cases. This substantial divergence is what’s fueling concerns about immune evasion. Early research suggests it could reduce the effectiveness of immunity gained from prior infections or vaccinations.

However, it’s crucial to remember that vaccines aren’t rendered useless. Viruses evolve, and BA.3.2 is simply exhibiting a characteristic common to all coronaviruses – adapting to overcome the defenses we build against them.

Current Severity and Spread

Currently, there’s no evidence to suggest that BA.3.2 causes more severe illness than other circulating strains. Reported cases in the U.S. Have been relatively mild, and there hasn’t been a corresponding spike in deaths linked specifically to this variant. Despite this, COVID-19 continues to claim approximately 100,000 American lives each year, with older adults and immunocompromised individuals remaining particularly vulnerable.

Wastewater data indicates that BA.3.2 is more widespread than traditional testing methods reveal. This underscores the importance of wastewater surveillance as an early warning system for emerging variants.

Global Monitoring and the “Variant Under Monitoring” Designation

The World Health Organization (WHO) has classified BA.3.2 as a “variant under monitoring,” reflecting the need for continued vigilance. The variant has been detected in over 20 countries, including Japan, Kenya, Germany, Denmark, the Netherlands, and the United Kingdom. In some European regions, it already accounts for nearly 30% of sequenced cases.

The Future of COVID-19: A Constant Evolution

The emergence of BA.3.2 reinforces the understanding that COVID-19 is not a static threat. It’s a virus that will continue to evolve, seeking ways to overcome our immunity. This necessitates ongoing monitoring, research, and adaptation of public health strategies.

The focus is shifting towards managing COVID-19 as an endemic disease, similar to the flu. This means accepting a certain level of ongoing transmission while minimizing severe illness and protecting vulnerable populations. Continued development of updated vaccines and treatments will be crucial in this effort.

FAQ

Q: Is the “Cicada” variant more dangerous than previous strains?
A: Currently, there’s no evidence to suggest it causes more severe illness. However, its ability to evade immunity is a concern.

Q: Will my COVID-19 vaccine protect me against BA.3.2?
A: Vaccines may be less effective at preventing infection, but they still offer protection against severe illness, hospitalization, and death.

Q: What are the symptoms of the BA.3.2 variant?
A: Symptoms are similar to those of other COVID-19 variants, including cough, fatigue, and sore throat.

Q: How is BA.3.2 being tracked?
A: Through traditional testing, wastewater surveillance, and monitoring of clinical samples.

Q: Where has BA.3.2 been detected?
A: The variant has been detected in at least 25 U.S. States and over 20 countries worldwide.

Did you know? Wastewater surveillance is becoming an increasingly important tool for tracking the spread of COVID-19 and identifying new variants.

Stay informed about the latest developments regarding COVID-19 and consult with your healthcare provider for personalized advice.

You may also like

Leave a Comment